Summers Benjamin D, Omar Muhiadin, Ronson Thomas O, Cartwright Jared, Lloyd Michael, Grogan Gideon
B.D. Summers, M. Omar, T. Ronson, Dr G. Grogan, York Structural Biology Laboratory, Department of Chemistry University of York, York YO10 5DD, UK.
Org Biomol Chem. 2015 Feb 14;13(6):1897-903. doi: 10.1039/c4ob01441c.
The Baeyer-Villiger monooxygenase (BVMO) 'MO14' from Rhodococcus jostii RHA1, is an enantioselective BVMO that catalyses the resolution of the model ketone substrate bicyclo[3.2.0]hept-2-en-6-one to the (1S,5R)-2-oxa lactone and the residual (1S,5R)-substrate enantiomer. This regio-plus enantioselective behaviour is highly unusual for BVMOs, which often perform enantiodivergent biotransformations of this substrate. The scaleability of the transformation was investigated using fermentor-based experiments, in which variables including gene codon optimisation, temperature and substrate concentration were investigated. E. coli cells expressing MO14 catalysed the resolution of bicyclo[3.2.0]hept-2-en-6-one to yield (1S,5R)-2-oxa lactone of >99% ee and (1S,5R)-ketone of 96% ee after 14 h at a temperature of 16 °C and a substrate concentration of 0.5 g L(-1) (4.5 mM). MO14 is thus a promising biocatalyst for the production of enantio-enriched ketones and lactones derived from the [3.2.0] platform.
来自约氏红球菌RHA1的拜耳-维利格单加氧酶(BVMO)“MO14”是一种对映选择性BVMO,它能将模型酮底物双环[3.2.0]庚-2-烯-6-酮拆分得到(1S,5R)-2-氧杂内酯和残留的(1S,5R)-底物对映体。这种区域和对映选择性行为对于BVMO来说非常不寻常,因为BVMO通常对该底物进行对映发散性生物转化。使用基于发酵罐的实验研究了该转化反应的可扩展性,其中研究了包括基因密码子优化、温度和底物浓度等变量。表达MO14的大肠杆菌细胞在16°C温度和0.5 g L⁻¹(4.5 mM)底物浓度下培养14小时后,能将双环[3.2.0]庚-2-烯-6-酮拆分,生成对映体过量(ee)>99%的(1S,5R)-2-氧杂内酯和ee为96%的(1S,5R)-酮。因此,MO14是一种有前景的生物催化剂,可用于生产源自[3.2.0]平台的对映体富集的酮和内酯。